Therapeutic potential of neurotrophic factors for neurological disorders

Annals of Neurology

Volumn 40, Issue 3, 1996, Pages 346-354

  Yuen, Eric C ^a,c   Mobley, William C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIAL; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG EFFICACY; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERALGESIA; LIVER TOXICITY; MYALGIA; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NEUROPATHY; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029812881     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400304     Document Type: Review

References (79)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-1162
2. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995;270:593-598
3. Schecterson LC, Bothwell M. Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons. Neuron 1992;9:449-463
4. Maisonpierre PC, Belluscio L, Friedman B, et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 1990;5: 501-509
5. Koliatsos VE, Clatterbuck RE, Winslow JW, et al. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 1993;10:359-367
6. DiCicco-Bloom E, Friedman WJ, Black IB. NT-3 stimulates sympathetic neuroblast proliferation by promoting precursor survival. Neuron 1993;11:1101-1111
7. Gold BG, Mobley WC, Matheson SF. Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor. J Neurosci 1991; 11:943-955
8. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995;18:223-253
9. Longo FM, Holtzman DM, Grimes ML, Mobley WC. Nerve growth factor: actions in the peripheral and central nervous systems. In: Loughlin SE, Fallon JH, eds. Neurotrophic factors. New York: Academic, 1993:209-256
10. Johnson EM, Gorin PD, Brandeis LD, Pearson J. Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 1980;210:916-918
11. Aloe L, Cozzari C, Calissano P, Levi-Montalcini R. Somatic and behavioral postnatal effects of fetal injections of nerve growth factor antibodies in the rat. Nature 1981;291:413-415
12. Crowley C, Spencer SD, Nishimura MC, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994;76:1001-1011
13. Smeyne RJ, Klein R, Schnapp A, et al. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 1994;368:246-249
14. Holtzman DM, Kilbridge J, Li Y, et al. TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons. J Neurosci 1995;15:1567-1576
15. Li Y, Holtzman DM, Kromer LF, et al. Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J Neurosci 1995;15:2888-2905
16. Bjerre B, Bjorklund A, Mobley W, Rosengren E. Short- and long-term effects of nerve growth factor on the sympathetic nervous system in the adult mouse. Brain Res 1975;94:263-277
17. Diamond J, Holmes M, Coughlin M. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J Neurosci 1992;12:1454-1466
18. Rich KM, Disch SP, Eichler ME. The influence of regeneration and nerve growth factor on the neuronal cell body reaction to injury. J Neurocytol 1989;18:569-576
19. Lindsay RM. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci 1988;8:2394-2405
20. Apfel SC, Lipton RB, Arezzo JC, Kessler JA. Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 1991; 29:87-90
21. Apfel SC, Arezzo JC, Lipson L, Kessler JA. Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992; 31:76-80
22. Brewster WJ, Fernyhough P, Diemel LT, et al. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 1994; 17:321-325
23. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR. Expression of neuropeprides in experimental diabetes: effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Brain Res Mol Brain Res 1994;21:171-175
24. Apfel SC, Arezzo JC, Brownlec M, et al. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994;634:7-12
25. Faradji V, Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 1990;81:402-406
26. Rask C, Apfel S, Adornato B, et al. An overview of the clinical experience with systemic administration of nerve growth factor in treating peripheral nervous system disorders. Ann Neurol 1995;38:317
27. Petty BG, Cornblath DR, Adornato BT, et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994;36:244-246
28. Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 1993;13:2136-2148
29. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 1994;6:1903-1912
30. Lindsay RM. Brain-derived neurotrophic factor: an NGF-related neurotrophin. In: Loughlin SE, Fallon JH, eds. Neurotrophic factors. New York: Academic, 1993:257-284
31. Ernfors P, Lee KF, Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 1994; 368:147-150
32. Jones KR, Farinas I, Backus C, Reichardt LF. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 1994; 76:989-999
33. Klein R, Smeyne RJ, Wurst W, et al. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 1993;75:113-122
34. Henderson CE, Camu W, Mettling C, et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993;363:266-270
35. Sendtner M, Holtmann B, Kolbeck R, et al. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992;360:757-759
36. Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992;360:753-755
37. Oppenheim RW, Yin QW, Prevette D, Yan Q. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 1992;360:755-757
38. Li L, Oppenheim RW, Lei M, Houenou LJ. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J Neurobiol 1994;25:759-766
39. Yan Q, Matheson C, Lopez OT, Miller JA. The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor. J Neurosci 1994;14:5281-5291
40. Meyer M, Matsuoka I, Wetmore C, et al. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J Cell Biol 1992;119:45-54
41. Mitsumoto H, Bradley WG. Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain 1982;105:811-834
42. Mitsumoto H, Ikeda K, Klinkosz B, et al. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 1994;265:1107-1110
43. Ikeda K, Klinkosz B, Greene T, et al. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 1995;37:505-511
44. Bradley WG, the BDNF Trial Group. A phase I/II study of recombinant human brain-derived neurotrophic factor in patients with amyotrophic lateral sclerosis. Ann Neurol 1995;38:971
45. Hohn A, Leibrock J, Bailey K, Barde YA. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 1990;344: 339-341
46. Lamballe F, Klein R, Barbacid M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 1991;66:967-979
47. Hory-Lee F, Russell M, Lindsay RM, Frank E. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci USA 1993;90:2613-2617
48. Oppenheim RW, Prevette D, Haverkamp LJ, et al, Biological studies of a putative avian muscle-derived neurotrophic factor that prevents naturally occurring motoneuron death in vivo. J Neurobiol 1993;24:1065-1079
49. Eriksson NP, Lindsay RM, Aldskogius H. BDNF and NT-3 rescue sensory but not motoneurones following axotomy in the neonate. Neuroreport 1994;5:1445-1448
50. Ernfors P, Lee KF, Kucera J, Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994;77:503-512
51. Farinas I, Jones KR, Backus C, et al. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994; 369:658-661
52. Klein R, Silos-Santiago I, Smeyne RJ, et al. Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature 1994;308: 249-251
53. DiStefano PS, Friedman B, Radziejewski C, et al. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 1992;8:983-993
54. Gao WQ, Dybdal N, Shinsky N, et al. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 1995;38:30-37
55. Elias KA, Shinsky N, Ingle G, et al. Neurotrophin-3 (NT-3) treatment maintains myclinated nerve fiber profiles and prevents A-fiber function loss in diabetic rats. Soc Neurosci Abstr 1995;21:1055
56. Sendtner M, Carroll P, Holtmann B, et al. Ciliary neurotrophic factor. J Neurobiol 1994;25:1436-1453
57. Stahl N, Yancopoulos GD. The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines. J Neurobiol 1994;25:1454-1466
58. Oppenheim RW, Prevette D, Yin QW, et al. Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 1991;251:1616-1618
59. Sendtner M, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 1990;345:440-441
60. Gurney ME, Yamamoto H, Kwon Y. Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and basic fibroblast growth factor. J Neurosci 1992;12:3241-3247
61. Sahenk Z, Seharaseyon J, Mendell JR. CNTF potentiates peripheral nerve regeneration. Brain Res 1994;655:246-250
62. Mitsumoto H, Ikeda K, Holmlund T, et al. The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 1994;36:142-148
63. Shapiro L, Zhang XX, Rupp RG, et al. Ciliary neurotrophic factor is an endogenous pyrogen. Proc Natl Acad Sci USA 1993;90:8614-8618
64. Henderson JT, Seniuk NA, Richardson PM, et al. Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J Clin Invest 1994;93:2632-2638
65. Dittrich F, Thoenen H, Sendtner M. Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat. Ann Neurol 1994;35:151-163
66. ALS CNTF Treatment Study (ACTS) Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 1996;46:1244-1249
67. Miller RG, Petajan JH, Bryan WW, et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann Neurol 1996;39: 256-260
68. Ishii DN, Glazner GW, Pu SF. Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol Ther 1994; 62:125-144
69. Lewis ME, Neff NT, Contreras PC, et al. Insulin-like growth factor-I: potential for treatment of motor neuronal disorders. Exp Neurol 1993;124:73-88
70. Lewis ME, Vaught JL, Neff NT, et al. The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disorders. Ann NY Acad Sci 1993;692:201-208
71. Neff NT, Prevette D, Houenou LJ, et al. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J Neurobiol 1993;24:1578-1588
72. Hughes RA, Sendtner M, Thoenen H. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neurosci Res 1993;36:663-671
73. Caroni P, Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J Cell Biol 1990;110:1307-1317
74. Hansson HA, Dahlin LB, Danielsen N, et al. Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves. Acta Physiol Scand 1986;126:609-614
75. Glazner GW, Morrison AE, Ishii DN. Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration. Brain Res Mol Brain Res 1994;25:265-272
76. Nachemson AK, Lundborg G, Hansson HA. Insulin-like growth factor I promotes nerve regeneration: an experimental study on rat sciatic nerve. Growth Factors 1990;3:309-314
77. Contreras PC, Steffler C, Vaught JL. rhIGF-I enhances functional recover from sciatic crush. Time-course and dose-response study. Ann NY Acad Sci 1993;692:314-316
78. Lai EC, Felice K, Festoff BW, et al. A double-blind, placebo-controlled study of recombinant human insulin-like growth factor 1 in the treatment of amyotrophic lateral sclerosis. Ann Neurol 1995;38:971
79. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987;22:328-333